The American Conference Institute’s Annual Passport to Proficiency on the Essentials of Hatch-Waxman and BPCIA returns for its fifth iteration, offering a comprehensive primer on the intellectual property and regulatory fundamentals governing small molecules and biologics for brand names, generics and biopharmaceuticals.
WilmerHale Partner Tim Cook will present on the panel “In-Depth Drill-Down on Bioequivalence and Interchangeability for Small and Large Molecules”, exploring the regulatory and legal complexities surrounding bioequivalence and interchangeability in both small-molecule drugs and biologics.
